The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 08, 1999

Filed:

Feb. 12, 1993
Applicant:
Inventors:

Lori A Truitt, Golden, CO (US);

Frank Corbin, III, Littleton, CO (US);

Donn D Lobdell, Corona Del Mar, CA (US);

Douglas P Miller, Broomfield, CO (US);

Keith Manica, Lakewood, CO (US);

George J Eilers, Evergreen, CO (US);

Steven H Johnson, Lakewood, CO (US);

Lawrence L Leppert, Littleton, CO (US);

Assignee:

COBE Laboratories, Inc., Lakewood, CO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01D / ; B01D / ; B01D / ; A61M / ;
U.S. Cl.
CPC ...
210645 ; 210 85 ; 210 86 ; 210 87 ; 210 90 ; 210 961 ; 210 97 ; 210103 ; 210134 ; 210143 ; 2102572 ; 210258 ; 210646 ; 210650 ; 210739 ; 210741 ; 210929 ; 364184 ; 364185 ; 364188 ; 364189 ; 604-4 ; 604-5 ; 604 65 ; 604 67 ;
Abstract

Blood from a patient is treated extracorporeally by any selected one of a plurality of predetermined treatments. Each of the treatments involves the flow of blood from the patient into a primary chamber of a filtration unit, past a semipermeable membrane located in the filtration unit which separates the primary chamber from a secondary chamber of the filtration unit, out the filtration unit and back to the patient. A replacement fluid is selectively and controllably added to the blood, as required for the selected treatment. A secondary fluid is controllably and selectively introduced into the secondary chamber of the filtration unit for controllably collecting material passing across the semipermeable membrane from the blood or for supplying material to pass across the semipermeable membrane into the blood as required for the selected treatment. Materials are removed from the secondary chamber and collected in accordance with the selected treatment. Upon selection of one of the plurality of extracorporeal blood treatments available, the rates of blood flow, fluid flow and fluid collection during the extracorporeal treatment are automatically determined, established and monitored in accordance with the selected treatment. An apparatus which automatically performs and monitors the selected treatment is also described.


Find Patent Forward Citations

Loading…